SCHEMBL285510

SCHEMBL285510

CCCOC(=O)Nc1nc(=O)n([C@@H]2O[C@H](C)[C@@H](OC(C)=O)[C@H]2OC(C)=O)cc1F

nearest known ligand 0.65

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.65
ADK P55263 1/20 0.40
TDP1 Q9NUW8 2/20 0.34
SMN1; SMN2 Q16637 3/20 0.34
THRB P10828 1/20 0.34
HIF1A Q16665 1/20 0.34
TP53 P04637 2/20 0.32
NPC1 O15118 1/20 0.32
RAB9A P51151 1/20 0.32
HPGD P15428 1/20 0.32
MAPT P10636 2/20 0.32
ALDH1A1 P00352 1/20 0.32
P2RY6 Q15077 2/20 0.31
P2RY14 Q15391 2/20 0.31
TSHR P16473 1/20 0.31
PMP22 Q01453 1/20 0.31
HBB P68871 1/20 0.31
ACHE P22303 2/20 0.30
NT5E P21589 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9056539 0.95 LMNA (0.70) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL13340646 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL12302015 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL285059 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL12302023 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL12029798 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL12945763 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL8196421 0.94 LMNA (0.75) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL8992747 0.93 LMNA (0.73) LMNAADKTDP1SMN1; SMN2THRB
SCHEMBL285464 0.93 LMNA (0.73) LMNAADKTDP1SMN1; SMN2THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2428213-A1 STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUOROPYRIMIDINES FOR USE IN CANCER TREATMENT Nuvo Research AG (CH) 2012-03-14 EP claimed
EP-0602454-B1 N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines HOFFMANN LA ROCHE (CH) 1996-04-24 EP claimed
EP-0602454-A1 N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines F. HOFFMANN-LA ROCHE AG (CH) 1994-06-22 EP claimed
EP-2428213-A1 STABILIZED CHLORITE SOLUTIONS IN COMBINATION WITH FLUOROPYRIMIDINES FOR USE IN CANCER TREATMENT Nuvo Research AG (CH) 2012-03-14 EP disclosed
EP-0602454-B1 N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines HOFFMANN LA ROCHE (CH) 1996-04-24 EP disclosed
EP-0602454-A1 N-Oxycarbonyl substituted 5'-deoxy-5-fluorocytidines F. HOFFMANN-LA ROCHE AG (CH) 1994-06-22 EP disclosed